Reviva Labs, Multi-Factor Brightening Creme, 2 oz Discount

Description

• Clarifies uneven skin tone and dark spots and improves overall radiance.
• Refines skin’s textural appearance for a younger-looking complexion.
• Improve appearance of blemished skin and reduces appearance of acne scars.
• Featuring 10% Azelaic Acid, 5% Niacinamide, 3% Kojic Acid, 3% Tranexamic Acid.

What happens when you combine two unique acids (Azelaic Acid and Tranexamic Acid) with two proven brightening ingredients then add a dash of something special? You get a product unmatched at improving the appearance of skin discolorations and dark spots while visibly enhancing your skin’s textural appearance. Get ready to even your skin tone and reduce the appearance of acne scarring, as you create a more youthful-looking and lustrous complexion. NOTE: This product does darken in the jar overtime, starting out off-white and changing to a darker brown.

Packaging

2 oz

Suggested Use

Massage into areas of concern daily. Can be used day & night. During daytime, use sunscreen after.

About Reviva Labs

Since our founding in 1973, Reviva Labs has had one goal – to create safe, effective skin treatments that produce visible results… at a reasonable price.

Great natural skin care that’s affordable and works! That’s why generations of skin care enthusiasts have fallen in love with our skin care over the last five decades. It makes us smile when we hear from families who are using our products –grandmothers, daughters, and granddaughters too.

Safety

Please consult your health care provider if currently under care or treatment or for pregnancy, nursing, and child safety instructions. Keep out of reach of children. Do not exceed recommended serving. See product packaging for additional safety information.

Disclaimer

Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.